OtherChemotherapy, Antibiotics, and Gene Therapy
Agent-based modelling reveals the role of the tumour microenvironment on the short-term success of combination temozolomide/immune checkpoint blockade to treat glioblastoma
Anudeep Surendran, Adrianne L Jenner, Elham Karimi, Benoit Fiset, Daniela F Quail, Logan A Walsh and Morgan Craig
Journal of Pharmacology and Experimental Therapeutics July 13, 2023, JPET-AR-2022-001571; DOI: https://doi.org/10.1124/jpet.122.001571
Anudeep Surendran
1Mathematics and Statistics, Université de Montréal, Canada
Adrianne L Jenner
2School of Mathematical Sciences, Queensland University of Technology, Australia
Elham Karimi
3Rosalind and Morris Goodman Cancer Institute, McGill University, Canada
Benoit Fiset
3Rosalind and Morris Goodman Cancer Institute, McGill University, Canada
Daniela F Quail
3Rosalind and Morris Goodman Cancer Institute, McGill University, Canada
Logan A Walsh
3Rosalind and Morris Goodman Cancer Institute, McGill University, Canada
Morgan Craig
4Sainte-Justine University Hospital Research Centre, Canada

Jump to comment:
No eLetters have been published for this article.
In this issue
OtherChemotherapy, Antibiotics, and Gene Therapy
Agent-based model of combination treatment for glioblastoma
Anudeep Surendran, Adrianne L Jenner, Elham Karimi, Benoit Fiset, Daniela F Quail, Logan A Walsh and Morgan Craig
Journal of Pharmacology and Experimental Therapeutics July 13, 2023, JPET-AR-2022-001571; DOI: https://doi.org/10.1124/jpet.122.001571
OtherChemotherapy, Antibiotics, and Gene Therapy
Agent-based model of combination treatment for glioblastoma
Anudeep Surendran, Adrianne L Jenner, Elham Karimi, Benoit Fiset, Daniela F Quail, Logan A Walsh and Morgan Craig
Journal of Pharmacology and Experimental Therapeutics July 13, 2023, JPET-AR-2022-001571; DOI: https://doi.org/10.1124/jpet.122.001571
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement